CAS: 3034-41-1; 1-Methyl-4-Nitroimidazole

该化合物是一种有机化合物,其特点是有5个成分的单体环,含有两个氮原子,由5个成份组成的循环结构,其特征是甲基组和与一氮原子环相连的硝化物组,其化学反应性及特性有助于该产品化学反应和特性,一般是晶状固体,由于硝基化合物组的存在而溶于极溶剂中,这增加了其极度,硝基罗组还具有重要的电子抽取特性,影响该化合物在各种化学反应中的再活动,例如核分裂替代物和电动力替代物.1-甲基-4-硝基氨基甲酸,因其潜在的生物活动,在各个领域,包括制药和农用化学品领域都具有意义.应当考虑到安全因素,因为硝基苯化合物可能危险,可能需要小心处理和储存.总体而言,该化合物体现了硝基替代乙基乙基血循环的各种化学成分.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号3034-38-6 4-硝基咪唑 | CAS号74-88-4 碘甲烷 | CAS号616-38-6 碳酸二甲酯 | CAS号553-90-2 草酸二甲酯 | CAS号60314-39-8 cis-bis(ethylen... | CAS号77-78-1 硫酸二甲酯 | CAS号616-47-7 N-甲基咪唑 | CAS号19182-81-1 1,4-二硝基咪唑 | CAS号74-89-5 氨基甲烷 | CAS号107-97-1 肌氨酸 | CAS号7664-41-7 氨 | CAS号74-89-5 氨基甲烷 | CAS号19183-15-4 1-methyl-4,5-di... | CAS号3034-43-3 Imidazolium, 1,... | CAS号1208893-80-4 2,6-二氯-N-(1-甲基-... | CAS号79578-98-6 1-甲基咪唑-4-胺 | CAS号89088-69-7 1-甲基-1H-咪唑-4-胺盐酸盐 | CAS号89303-10-6 2-(benzenesulfo...

合成工艺路线路线简述

    N-甲基咪唑置于sodium Nitrate体系中,用 Neat (No Solvent) 用作溶剂,化学反应 1.0H,以78%的收率获得1-甲基-4-硝基咪唑
    参考文献:磁性可循环利用的核/壳纳米复合材料催化芳香化合物硝化的高效方案
    标题:磁性可循环利用的核/壳纳米复合材料催化芳香化合物硝化的高效方案
    摘要:报道了在催化量的硫酸官能化的二氧化硅基磁性核/壳纳米复合材料存在下硝化芳族化合物的有效方案.在无溶剂条件下,在室温下以相对较短的反应时间以高收率获得了设计产品.通过使用外部磁体,可以简单地从反应混合物中回收纳米催化剂,并有效地重复使用几次.通过扫描电子显微镜,透射电子显微镜和能量色散x射线光谱分析分别提供了纳米催化剂的粒度表征,形态和元素分析.
    Doi:10.1007/s13738-016-0996-6

    海关参考信息

    专利信息


    专利号:US-12037636-B2
    优先权日:2018-07-19
    标题 :Polynucleotide synthesis method, kit and system
    发明人:MILTON JOHN; NAYYAR SOBIA; RIEDL JAN; OGAKI RYOSUKE
    权利人:OXFORD NANOPORE TECH PLC
    摘要:The invention relates to new methods for synthesising polynucleotide molecules according to a predefined nucleotide sequence. The invention also relates to methods for the assembly of synthetic polynucleotides following synthesis, as well as systems and kits for performing the synthesis and/or assembly methods.

    专利号:US-7211668-B2
    优先权日:2003-07-28
    标 题 :PNA monomer and precursor
    发明人:KIM SUNG KEE; LEE HYUNIL; LIM JONG CHAN; LEE SUNG HEE
    权利人:PANAGENE INC
    摘要:This application relates to monomers of the general formula (I) for the preparation of PNA (peptide nucleic acid) oligomers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: n nwhereinn E is sulfur or oxygen; J is nitrogen or C—R′; R1, R′ is independently H, halogen, alkyl, nitro, nitrile, alkoxy, halogenated alkyl, halogenated alkoxy or a functional group having one of following general formulae: n nwhereinn A 1 , A 2 , A 3 , A 4 , A 5 , is independently selected from H, halogen such as F, Cl, Br or I, CF 3 , alkyl, preferably C 1 –C 4 alkyl, nitro, nitrile, alkoxy, preferably C 1 –C 4 alkoxy, halogenated (such as F, Cl, Br and I) alkyl, preferably halogenated C 1 –C 4 alkyl, halogenated (such as F, Cl, Br and I) alkoxy, preferably halogenated C 1 –C 4 alkoxy, phenyl, and halogenated (such as F, Cl, Br and I phenyl; R2 is H or protected or unprotected side chain of natural or unnatural α-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases in the presence of thiol.

    专利号:US-7411065-B2
    优先权日:2002-04-26
    标 题 :PNA monomer and precursor
    发明人:KIM SUNG KEE; LEE HYUNIL; LIM JONG CHAN; CHOI HOON; JEON JAE HOON; AHN SANG YOUL; LEE SUNG HEE; YOON WON JUN
    权利人:PANAGENE INC
    摘要:This application relates to monomers of the general formula (I) for the preparation of PNA (peptide nucleic acid) oglimers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: n nwhereinn E is nitrogen or C—R′; J is sulfur or oxygen; R′, R1, R2, R3, R4 is independently H, halogen, alkyl, nitro, nitrile, alkoxy, halogenated alkyl, halogenated alkoxy, phenyl or halogenated phenyl, R5 is H or protected or unprotected side chain of natural or unnatural α-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases in the presence of thiol.

    专利号:US-2007276139-A1
    优先权日:2004-02-10
    标题:Substituted Pixyl Protecting Groups for Oligonucleotide Synthesis
    发明人:SONG QUANLAI; KHAMMUNGKHUNE SAK; ROSS BRUCE S; GRIFFEY RICHARD H
    权利人:SONG QUANLAI; KHAMMUNGKHUNE SAK; ROSS BRUCE S; GRIFFEY RICHARD H
    摘要:The present invention describes an improved hydroxyl protecting group of formula (1), wherein R 2 and R 7 are specified substituents and Q is O, S, NR 10 or N(Câ•?O)R 10 .

    专利号:US-2007179100-A1
    优先权日:2003-04-09
    标 题:Protected monomers
    发明人:MANOHARAN MUTHIAH
    权利人:MANOHARAN MUTHIAH
    摘要:This invention relates to protected monomers for the synthesis of iRNA agents.

    专利号:US-7022851-B2
    优先权日:2002-01-24
    标题 :PNA monomer and precursor
    发明人:KIM SUNG KEE; LEE HYUNIL; LIM JONG CHAN; CHOI HOON; JEON JAE HOON; AHN SANG YOUL; LEE SUNG HEE
    权利人:PANAGENE INC
    摘要:This application relates to monomers of the general formula (I) for the preparation of PNA (peptide nucleic acid) oligomers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: n nwhereinn R1, R2, R3, R4, R5 is independently H, halogen, C 1 –C 4 alkyl, nitro, nitrile, C 1 –C 4 alkoxy, halogenated C 1 –C 4 alkyl, or halogenated C 1 –C 4 alkoxy, wherein at least one of R1, R3, and R5 is nitro; R6 is H or protected or unprotected side chain of natural or unnatural α-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases.
    南京一番化成生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.yfbiotech.com/
    电话: 025-025-52700520 18914499889👤
    📞南京一番化成生物科技有限公司 ⚠️参考联系方式

    销售电话:025-025-52700520 18914499889
    邮箱:sales@yfbiotech.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    绵阳凯新医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chemget.com.cn/
    电话: 816-816-2551723 18681628050👤
    📞绵阳凯新医药科技有限公司 ⚠️参考联系方式

    销售电话:816-816-2551723 18681628050
    邮箱:sales@chemget.com.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Nakao, Y., Science of Synthesis: Catalytic Transformations via CH Activation, (2015) 1, 410.
    摘要:Ruan, Z.; Huang, Z.; Kuciński, K.; Ackermann, L., Science of Synthesis: Special Topics, (2021) 1, 237.
    摘要:Mitsudo, K.; Suga, S., Science of Synthesis, (2020) , 448.
    摘要:A. Grimison, J. H. Ridd, and B. V. Smith. J. Chem. Soc. 1960, 1352.
    参考文献:10.1007/bf02988836
    摘要:Subar M, Gucalp R, Benstein J, Williams G, Wiernik PH. Acute leukaemia following renal transplantation. Med Oncol. 1996 Mar;13(1):9–13. doi: 10.1007/bf02988836.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知